The “Cooperation Advantage and Innovative Technology of CRO’s New Drug Development Forum” was held in Nanjing BSK Community on December 5. The CEO of Medicilon, Dr. Chunlin Chen, was invited to give a speech in the forum.
Medicilon’s VP of Biology, Dr. Jun Wang was invited to give a speech on UK-China Partners for Growth and Innovation in Biopharmaceuticals Forum & Partnership Workshop
Medicilon recently purchased a Biological Research Irradiator from Rad Source, a US company which specialized in irradiators.
Professor Jianhua Zhu, the former director of the Department of Pharmacy at Fudan University, was employed to work for Medicilon starting from Oct 2014.
Medicilon is always keen on continuous exploring on drug development. Recently, Medicilon signed a strategic cooperation agreement with Kuming Pharmaceutical Corporation, Simcere Pharmaceuticals Group and other pharmaceutical companies.